This review focuses on the biological processes of TGF-β, its dual role in the development of liver fibrosis, and the application of TGF-β inhibitors in liver fibrosis treatment, exploring previous research progress, clinical achievements, and future development trends. The gene discussed is TGFB1; the disease is Hepatic fibrosis.